AgomAb CEO Tim Jasper Knotnerus buys $94,880 of common shares
AGMB•AgomAb Therapeutics CEO Tim Jasper Knotnerus bought 11,000 common shares in open-market transactions at $8.48–$8.70, raising his directly held stake to 21,823 shares.
1. Share purchases
Knotnerus bought 11,000 common shares in open-market transactions priced at $8.48–$8.70. His directly held stake rose to 21,823 shares; 34,394 shares were separately reported as indirectly held through TJK Life Sciences B.V.
